Guardant Health Lifts 2026 Revenue Forecast to $1.30B-$1.32B on Strong Test Demand
The diagnostics firm cites 48% year-over-year growth in Q1 2026 revenue, driven by higher Shield test volumes. Guardant Health increased its 2026 revenue outlook to a range of $1.30 billion to $1.32 billion, up from prior guidance. The company reported $302 million in Q1 2